SOM Biotech announces the appointment of Alain Duguet Ph.D. as Head of Chemical Manufacturing and Control.
Read moreThe virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportuni...
Read moreSOM Biotech will participate in the Euronext webinar “Finance your tech company´s growth through capital markets” next June 25th.
Read moreSOM Biotech will attend BIO International Convention 2020 in its virtual format “BIO Digital” on June 8th – 12th.
Read moreSOM Biotech reoriented its capabilities to search for the treatments of COVID-19. Raúl Insa, CEO of SOM Biotech, acknowledges that he had never thought of using his technology to find treatment fo...
Read moreInterested in learning more about the role of Artificial Intelligence in Healthcare?
Read moreSOM Biotech, a clinical-stage drug discovery and development company, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19. The three candidates in...
Read moreWhile the coronavirus outbreak grows worldwide, at SOM Biotech we continue working on our pipeline to bring therapies for patients with rare diseases.
Read moreSOM Biotech will attend the Eyeforpharma Barcelona event that will be hosted online due to the impact of COVID-19, between March 31st and April 2nd 2020.
Read moreThe Rare Disease Day event will be focused on expert discussion tables chaired by the Catalan Health Department dedicated to sharing testimonies of affected patients and families.
Read moreSOM Biotech, compañía biofarmacéutica para la identificación, desarrollo - en fase preclínica y clínica – y comercialización de fármacos para el tratamiento de enfermedades huérfanas, princ...
Read moreSOM Biotech cierra una ronda de financiación de 7 millones de euros
Read more